Innovative Pharmaceuticals ETF Doubles Within the Year! 6 Innovative Pharmaceutical ETFs Rise Over 100%, and Hong Kong Stock Healthcare ETF Fund Rises 97%
Glon Union July 29th｜Innovative pharmaceutical ETF continues to explode, with year-end doubling ETF. HSBC Holdings Hong Kong Stock Healthcare ETF Fund, HuaAn Innovation Pharmaceutical ETF, W
Glon Union July 29th｜Innovative pharmaceutical ETF continues to explode, with year-end doubling ETF.
HSBC Holdings Hong Kong Stock Healthcare ETF Fund, HuaAn Innovation Pharmaceutical ETF, Wahai Hong Kong Stock Innovation Pharmaceutical Fund, Yinhua Hong Kong Stock Healthcare ETF, Guangfa Hong Kong Stock Healthcare ETF, and Jingxin Changcheng Hong Kong Stock 50 ETF have all risen over 100% within the year.
Hong Kong Stock Healthcare ETF Fund has risen 97% within the year; HuaAn Innovation Pharmaceutical ETF, Nanfang Innovation Biotechnology ETF, HSBC Holdings Innovation Biotechnology ETF, E-Fund Hong Kong Stock Healthcare ETF, and Dacheng Innovation Healthcare ETF have all risen over 80% within the year.